Repligen Financial Statements From 2010 to 2025

RGEN Stock

USD 150.17 1.11 0.74%

Repligen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Repligen's valuation are provided below:

Gross Profit

367.4 M

Profit Margin

0.0025

Market Capitalization

8.4 B

Enterprise Value Revenue

12.0891

Revenue

707.9 M

We have found one hundred twenty available trending fundamental ratios for Repligen, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to check out Repligen's recent fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 4th of November 2025, Market Cap is likely to grow to about 13.8 B. Also, Enterprise Value is likely to grow to about 13.5 B

Repligen Total Revenue

766.04 Million

Check Repligen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repligen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 45 M, Interest Expense of 23.7 M or Total Revenue of 766 M, as well as many indicators such as Price To Sales Ratio of 10.05, Dividend Yield of 0.0 or PTB Ratio of 3.02. Repligen financial statements analysis is a perfect complement when working with Repligen Valuation or Volatility modules.

Build AI portfolio with Repligen Stock

Check out the analysis of Repligen Correlation against competitors.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Repligen Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Short and Long Term Debt Total

720.6 M

686.2 M

263.8 M

Slightly volatile

Other Current Liabilities

69.6 M

66.3 M

27.8 M

Slightly volatile

Total Current Liabilities

133.1 M

126.8 M

112.6 M

Slightly volatile

Property Plant And Equipment Net

349.8 M

333.1 M

115.4 M

Slightly volatile

Cash

795.2 M

757.4 M

338 M

Slightly volatile

Non Current Assets Total

1.9 B

1.8 B

708.7 M

Slightly volatile

Non Currrent Assets Other

824.6 K

868 K

979.3 K

Very volatile

Cash And Short Term Investments

795.2 M

757.4 M

347.3 M

Slightly volatile

Net Receivables

140.8 M

134.1 M

54.9 M

Slightly volatile

Common Stock Shares Outstanding

30.7 M

55.9 M

40.2 M

Slightly volatile

Liabilities And Stockholders Equity

3 B

2.8 B

1.1 B

Slightly volatile

Non Current Liabilities Total

766.7 M

730.2 M

203.9 M

Slightly volatile

Inventory

150.1 M

143 M

77.6 M

Slightly volatile

Other Current Assets

33.2 M

31.6 M

12 M

Slightly volatile

Other Stockholder Equity

1.7 B

1.6 B

801.9 M

Slightly volatile

Total Liabilities

899.8 M

856.9 M

316.5 M

Slightly volatile

Property Plant And Equipment Gross

520.4 M

495.6 M

154.5 M

Slightly volatile

Total Current Assets

1.1 B

491.5 M

Slightly volatile

Accounts Payable

33.7 M

32.1 M

14 M

Slightly volatile

Short Term Debt

14.3 M

15.1 M

105.6 M

Pretty Stable

Common Stock Total Equity

389.2 K

639.4 K

426.7 K

Slightly volatile

Common Stock

406.9 K

561 K

423.4 K

Slightly volatile

Property Plant Equipment

230.2 M

219.3 M

75.2 M

Slightly volatile

Other Liabilities

94.6 M

90.1 M

38.2 M

Slightly volatile

Current Deferred Revenue

13.9 M

13.2 M

6 M

Slightly volatile

Good Will

1.1 B

1 B

477.6 M

Slightly volatile

Intangible Assets

417.8 M

397.9 M

173.4 M

Slightly volatile

Net Tangible Assets

847.1 M

806.7 M

368.2 M

Slightly volatile

Capital Surpluse

1.9 B

1.8 B

844.1 M

Slightly volatile

Non Current Liabilities Other

41.4 M

36.2 M

35.6 M

Slightly volatile

Deferred Long Term Asset Charges

2.2 M

2.9 M

2.5 M

Pretty Stable

Long Term Debt Total

156.7 M

267.7 M

161.7 M

Slightly volatile

Short and Long Term Debt

75.9 M

79.9 M

132.6 M

Slightly volatile

Net Invested Capital

1.9 B

2.5 B

1.3 B

Slightly volatile

Net Working Capital

630.1 M

939.3 M

421 M

Slightly volatile

Capital Stock

587.1 K

561 K

489.7 K

Slightly volatile

Capital Lease Obligations

110.8 M

160.7 M

61.9 M

Slightly volatile

Repligen Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

45 M

86.6 M

103.7 M

Slightly volatile

Total Revenue

766 M

634.4 M

1.8 B

Slightly volatile

Gross Profit

532.8 M

274.6 M

1.2 B

Slightly volatile

Other Operating Expenses

961.2 M

669.6 M

2.2 B

Slightly volatile

Cost Of Revenue

233.3 M

359.8 M

540 M

Slightly volatile

Total Operating Expenses

294.3 M

309.8 M

1.7 B

Slightly volatile

Research Development

41 M

43.2 M

612.4 M

Slightly volatile

Selling General Administrative

347.8 M

263.4 M

669.6 M

Slightly volatile

Net Income Applicable To Common Shares

224.5 M

213.9 M

71.2 M

Slightly volatile

Interest Income

4 M

4.6 M

2.7 M

Slightly volatile

Reconciled Depreciation

43.4 M

86.6 M

27 M

Slightly volatile

Extraordinary Items

7.7 M

8.6 M

9.4 M

Slightly volatile

Selling And Marketing Expenses

504.8 K

567.9 K

619.2 K

Slightly volatile

Repligen Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Begin Period Cash Flow

788.9 M

751.3 M

288.2 M

Slightly volatile

Depreciation

90.9 M

86.6 M

27 M

Slightly volatile

Capital Expenditures

30.5 M

32.9 M

60.7 M

Pretty Stable

End Period Cash Flow

795.2 M

757.4 M

335.5 M

Slightly volatile

Stock Based Compensation

49.8 M

48.1 M

16.4 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

10.05

12.6909

11.9304

Slightly volatile

PTB Ratio

3.02

4.0815

4.5108

Slightly volatile

Days Sales Outstanding

42.55

77.1579

61.9315

Very volatile

Average Payables

2.6 M

2.5 M

Slightly volatile

Stock Based Compensation To Revenue

0.072

0.0758

0.2522

Slightly volatile

Capex To Depreciation

0.36

0.3801

0.9676

Very volatile

PB Ratio

3.02

4.0815

4.5108

Slightly volatile

EV To Sales

9.0

12.5788

11.2803

Slightly volatile

Inventory Turnover

3.89

2.5167

2.8968

Slightly volatile

Days Of Inventory On Hand

133

145

175

Slightly volatile

Payables Turnover

11.76

11.1967

10.5348

Pretty Stable

Sales General And Administrative To Revenue

0.37

0.39

0.3167

Slightly volatile

Average Inventory

14.4 M

13.7 M

12.6 M

Slightly volatile

Research And Ddevelopement To Revenue

0.0647

0.0681

0.1926

Slightly volatile

Capex To Revenue

0.0958

0.0519

0.0728

Pretty Stable

Cash Per Share

14.22

13.5394

7.1157

Slightly volatile

Days Payables Outstanding

34.23

32.599

37.6057

Very volatile

Current Ratio

9.0

8.4081

6.6147

Very volatile

Receivables Turnover

4.49

4.7306

5.6757

Pretty Stable

Shareholders Equity Per Share

37.03

35.2668

17.6482

Slightly volatile

Debt To Equity

0.37

0.3479

0.3545

Slightly volatile

Capex Per Share

0.62

0.5883

0.4864

Slightly volatile

Graham Net Net

1.35

1.2957

2.5942

Pretty Stable

Average Receivables

8.1 M

7.7 M

8 M

Slightly volatile

Revenue Per Share

11.91

11.342

6.0575

Slightly volatile

Interest Debt Per Share

13.31

12.6718

4.5574

Slightly volatile

Debt To Assets

0.15

0.2425

0.304

Pretty Stable

Graham Number

11.18

20.26

15.5544

Slightly volatile

Operating Cycle

174

222

237

Slightly volatile

Price Book Value Ratio

3.02

4.0815

4.5108

Slightly volatile

Days Of Payables Outstanding

34.23

32.599

37.6057

Very volatile

Ebt Per Ebit

1.11

0.7699

1.0436

Slightly volatile

Long Term Debt To Capitalization

0.22

0.2104

0.2455

Slightly volatile

Total Debt To Capitalization

0.27

0.2581

0.2476

Pretty Stable

Debt Equity Ratio

0.37

0.3479

0.3545

Slightly volatile

Quick Ratio

8.43

7.2805

6.0519

Pretty Stable

Net Income Per E B T

1.17

0.9437

1.0976

Very volatile

Cash Ratio

5.47

5.9734

4.5107

Very volatile

Cash Conversion Cycle

180

190

204

Slightly volatile

Days Of Inventory Outstanding

133

145

175

Slightly volatile

Days Of Sales Outstanding

42.55

77.1579

61.9315

Very volatile

Free Cash Flow Operating Cash Flow Ratio

1.13

0.8124

0.7183

Slightly volatile

Price To Book Ratio

3.02

4.0815

4.5108

Slightly volatile

Fixed Asset Turnover

1.81

1.9046

4.2972

Slightly volatile

Debt Ratio

0.15

0.2425

0.304

Pretty Stable

Price Sales Ratio

10.05

12.6909

11.9304

Slightly volatile

Gross Profit Margin

0.69

0.4329

0.5437

Pretty Stable

Price Fair Value

3.02

4.0815

4.5108

Slightly volatile

Repligen Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

13.8 B

13.1 B

9.1 B

Slightly volatile

Enterprise Value

13.5 B

12.9 B

9 B

Slightly volatile

Repligen Fundamental Market Drivers

	Forward Price Earnings	74.0741
	Cash And Short Term Investments	757.4 M

Repligen Upcoming Events

	28th of February 2024 Upcoming Quarterly Report	View
	7th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	28th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About Repligen Financial Statements

Repligen investors utilize fundamental indicators, such as revenue or net income, to predict how Repligen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Current Deferred Revenue	13.2 M	13.9 M
Total Revenue	634.4 M	766 M
Cost Of Revenue	359.8 M	233.3 M
Stock Based Compensation To Revenue	0.08	0.07
Sales General And Administrative To Revenue	0.39	0.37
Research And Ddevelopement To Revenue	0.07	0.06
Capex To Revenue	0.05	0.10
Revenue Per Share	11.34	11.91
Ebit Per Revenue	(0.06)	(0.06)

Pair Trading with Repligen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Repligen Stock

0.94

Agilent Technologies Earnings Call Tomorrow

Pair Corr

Moving against Repligen Stock

0.85	PRM	Proteome Sciences PLC	Pair Corr
0.79	603882	Guangzhou Kingmed	Pair Corr
0.77	603108	Shanghai Runda Med	Pair Corr
0.69	CDT	Conduit Pharmaceuticals	Pair Corr
0.52	BPH	BPH Energy	Pair Corr

The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.

The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:

How To Invest In Repligen

Details

Is Repligen Stock a good investment?

Details

What is Repligen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Repligen Correlation against competitors.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.6

Earnings Share

0.02

Revenue Per Share

12.602

Quarterly Revenue Growth

0.219

Return On Assets

0.0113

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Repligen Financial Statements From 2010 to 2025

Repligen Total Revenue

766.04 Million

Repligen Balance Sheet

Repligen Income Statement

Repligen Cash Flow Statement

Financial Ratios

Repligen Valuation Data

Repligen Fundamental Market Drivers

Repligen Upcoming Events

About Repligen Financial Statements

Pair Trading with Repligen

Moving together with Repligen Stock

Moving against Repligen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY